Structure-Based Strategy Reveals a Novel Ligand Binding Site in Staphylococcus aureus Catabolite Control Protein A: Implications for Transcriptional Regulation and Drug Design
Abstract
Staphylococcus aureus is a major human pathogen responsible for a broad spectrum of infections and is recognized by the World Health Organization as a high-priority antimicrobial-resistant organism. The global transcription factor (TF) catabolite control protein A (CcpA), a central regulator of metabolism and virulence, represents a promising drug target. However, efforts to design inhibitors are hindered by their closed crystallographic conformation and the absence of well-defined ligand-binding cavities. Here, we present a structure-guided alignment strategy to identify potential ligand-binding sites in CcpA from S. aureus (Sa-CcpA), using a curated set of cocrystallized TFs as structural templates. This methodology identified a putative ligand-binding site in Sa-CcpA that was not predicted by conventional cavity-detection methods. Phylogenetic analysis showed that residues within this predicted cavity are conserved in a subset of particular pathogenic species in the order Bacillales, suggesting an evolutionarily constrained and functionally relevant region. To assess the stability of this newly identified site, multiple molecular dynamics simulations were performed, followed by docking analyses of two known Sa-CcpA inhibitors. Together, our results suggest that this structure-informed alignment strategy is a promising approach to uncover previously unrecognized ligand-binding regions in TFs. Although demonstrated here using Sa-CcpA as a case study, this approach may…
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.